Literature DB >> 24936942

Fibrovascular pigment epithelial detachment is a risk factor for long-term visual decay in neovascular age-related macular degeneretion.

Robert Hoerster1, Philipp S Muether, Vasilena Sitnilska, Bernd Kirchhof, Sascha Fauser.   

Abstract

BACKGROUND: The individual outcome of anti-vascular endothelial growth factor treatment in neovascular age-related macular degeneration is variable. To investigate the prognostic value of spectral domain optical coherence tomography structures for best-corrected visual acuity (BCVA) outcome, volumetric analysis of spectral domain optical coherence tomography structures was performed in neovascular age-related macular degeneration correlated with BCVA after 24 months.
METHODS: At the Department of Ophthalmology, University of Cologne, Germany, 75 patients with neovascular age-related macular degeneration were analyzed prospectively over 24 months. Patients received three initial consecutive monthly intravitreal ranibizumab injections followed by monthly spectral domain optical coherence tomography controls. Therapy was continued as a pro re nata regimen. Volumetric analysis of spectral domain optical coherence tomography images was performed using commercially available software (3D-Doctor).
RESULTS: Subretinal tissue, subretinal fluid, serous pigment epithelial detachment, and fibrovascular pigment epithelial detachment (FPED) were identified. By contrast to all other structures, FPED did not respond to ranibizumab therapy. Volume of FPED at baseline and after the loading phase correlated most with impaired BCVA after 24 months (r = -0.0215, P = 0.9263 [subretinal tissue]; r = -0.3120, P = 0.0216 [subretinal fluid]; r = -0.0757, P = 0.6470 [serous pigment epithelial detachment]; r = -0.4182, P = 0.0111 (FPED baseline); r = -0.4768; P = 0.0002 [FPED after loading phase]).
CONCLUSION: Of all identified structures, FPED was most deleterious for BCVA after 24 months. The knowledge about possible BCVA course can influence the decision for more intense treatment regimens.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24936942     DOI: 10.1097/IAE.0000000000000188

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  9 in total

1.  The overlapping spectrum of flat irregular pigment epithelial detachment investigated by optical coherence tomography angiography.

Authors:  Francesco Pichi; Mariachiara Morara; Chiara Veronese; Antonio P Ciardella
Journal:  Int Ophthalmol       Date:  2017-05-11       Impact factor: 2.031

2.  [Clinical parameters of patients with neovascular age-related macular degeneration : Longterm treatment results of an outpatient clinic].

Authors:  S Wassel; E Tsompanidi; E Tahmaz; B Hörster; R Hoerster
Journal:  Ophthalmologe       Date:  2019-05       Impact factor: 1.059

3.  Short-term outcomes of switching anti-VEGF agents in eyes with treatment-resistant wet AMD.

Authors:  Figen Batioglu; Sibel Demirel; Emin Özmert; Ahmet Abdullayev; Serdar Bilici
Journal:  BMC Ophthalmol       Date:  2015-04-11       Impact factor: 2.209

4.  Evaluation of Aflibercept Treatment Responses in Eyes with Bevacizumab/Ranibizumab-resistant Wet Age-related Macular Degeneration.

Authors:  Tuncay Topal; Taner Kar; Yıldıray Yıldırım; Sercan Koray Sağdıç; Cihan Büyükavşar; Abdullah Kaya; Ali Ayata; Murat Sönmez; Melih Hamdi Ünal
Journal:  Turk J Ophthalmol       Date:  2017-06-01

5.  The outcomes of aflibercept therapy in patients with age-related macular degeneration resistant to bevacizumab or ranibizumab.

Authors:  Erkan Unsal; Mehmet Ozgur Cubuk
Journal:  J Curr Ophthalmol       Date:  2018-08-09

Review 6.  Epidemiological and Clinical Baseline Characteristics as Predictive Biomarkers of Response to Anti-VEGF Treatment in Patients with Neovascular AMD.

Authors:  Miltiadis K Tsilimbaris; Maria I López-Gálvez; Roberto Gallego-Pinazo; Philippe Margaron; George N Lambrou
Journal:  J Ophthalmol       Date:  2016-03-17       Impact factor: 1.909

7.  Long-Term Visual/Anatomic Outcome in Patients with Fovea-Involving Fibrovascular Pigment Epithelium Detachment Presenting Choroidal Neovascularization on Optical Coherence Tomography Angiography.

Authors:  Kyung Tae Kim; Hwanho Lee; Jin Young Kim; Suhwan Lee; Ju Byung Chae; Dong Yoon Kim
Journal:  J Clin Med       Date:  2020-06-15       Impact factor: 4.241

8.  Fibrovascular pigment epithelial detachment in eyes with subretinal hemorrhage secondary to neovascular AMD or PCV: a morphologic predictor associated with poor treatment outcomes.

Authors:  Jae Hui Kim; Joo Yeon Kim; Dong Won Lee; Chul Gu Kim; Jong Woo Kim
Journal:  Sci Rep       Date:  2020-09-10       Impact factor: 4.379

9.  A Baseline Score to Predict Response to Ranibizumab Treatment in Neovascular Age-Related Macular Degeneration.

Authors:  Cheikh Diack; Dietmar Schwab; Valerie Cosson; Vincent Buchheit; Norman Mazer; Nicolas Frey
Journal:  Transl Vis Sci Technol       Date:  2021-05-03       Impact factor: 3.283

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.